Yurie Satoh-Kanda

5PUBLICATIONS
12CO-AUTHORS
AutoimmunityRegenerative medicine (incl. stem cells)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 31, 2026
Emerging treatment strategies in systemic lupus erythematosus: integrating molecular stratification, targeted therapy, and treatment response evaluation.

|Feb 05, 2026
Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry.

Hidenori Sakai, Koshiro Sonomoto, Shingo Nakayamada

|Jan 16, 2026
Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry.

Masanobu Ueno, Koshiro Sonomoto, Hiroaki Tanaka

|Jan 22, 2025
Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.

Yusuke Miyazaki, Shingo Nakayamada, Hiroaki Tanaka

|Dec 31, 2024
Fine-tuning SLE treatment: the potential of selective TYK2 inhibition.

Yurie Satoh-Kanda, Shingo Nakayamada, Yoshiya Tanaka

Pageof 1

Frequent Collaborators

5 joint publications

Yoshiya Tanaka

3 joint publications

Satoshi Kubo

3 joint publications

Masanobu Ueno

3 joint publications

Shingo Nakayamada